Premium
Reply to Woltsche N. et al . Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single‐centre experience
Author(s) -
Scalvenzi M.,
Costa C.,
Cappello M.,
Villani A.
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15469
Subject(s) - vismodegib , medicine , basal cell carcinoma , hedgehog signaling pathway , hedgehog , adverse effect , reduction (mathematics) , basal cell , oncology , basal (medicine) , signal transduction , biochemistry , chemistry , geometry , mathematics , insulin , gene